New Nasal Spray Drug for Anxiety Disorders May Be Beneficial for Managing HPPD Symptoms

[James3524]

Fasedienol is an investigational drug being developed by Vistagen Therapeutics for the treatment of anxiety disorders, primarily social anxiety disorder (SAD).

About:

• Mechanism of action: It's a pherine nasal spray that works differently from traditional anti-anxiety medications. It targets specific receptors in the nose, affecting brain regions related to anxiety.

• Potential benefits: Fasedienol is being studied for its rapid onset and short duration of action, which could be advantageous for managing acute anxiety symptoms.

• Clinical trials: It's currently in Phase 3 clinical trials for SAD, with positive results reported so far.

• Other potential uses: Research is also exploring its potential for treating generalized anxiety disorder (GAD) and post-traumatic stress disorder (PTSD).

• As fasedienol is very closely related structurally to androstadienol, it might be converted into androstenol similarly and hence potentiation of the GABAA receptor could contribute to its mechanism of action